Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03237364 · ClinicalTrials.gov registry record · Early Phase 1
Iraq- Afghanistan War Lung Injury Using 19F MRI (DIAL1001006)
A Early Phase 1 study, sponsored by Hal C Charles.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 7
- Enrollment target
NCT03237364 is a Early Phase 1 study that has completed, run by Hal C Charles. The registered enrollment target is 7 participants.
The verdict
NCT03237364, a Early Phase 1 study, has completed, sponsored by Hal C Charles.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate the utilization of conventional 'thermally' polarized perfluorinated gases mixed with oxygen as an exogenous inert contrast agent to image the airway spaces in subjects with suspected lung disease, post deployment in Iraq and Afghanistan. This is an open label proof of concept study expanding on work here at Duke.
Interventions
- DIAGNOSTIC_TEST Perfluorinated Gas/Oxygen Mixture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-08-19 |
| Est. Completion | 2020-02-28 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03237364
The ClinicalTrials.gov registry entry for NCT03237364 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hal C Charles, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Perfluorinated Gas/Oxygen Mixture is the first listed.
NCT03237364 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03237364 about?
NCT03237364 is a clinical study titled "Iraq- Afghanistan War Lung Injury Using 19F MRI (DIAL1001006)". The goal of this study is to evaluate the utilization of conventional 'thermally' polarized perfluorinated gases mixed with oxygen as an exogenous inert contrast agent to image the airway spaces in subjects with suspected lung disease, post deployment in Iraq and Afghanistan. This is an open label p...
What is the current status of trial NCT03237364?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 7 participants. The study started on 2017-08-19. Estimated completion is 2020-02-28.
What interventions are being tested in trial NCT03237364?
The interventions under investigation include: Perfluorinated Gas/Oxygen Mixture (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03237364?
This trial is sponsored by Hal C Charles, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.